Eva Kimby

Karolinska University Hospital

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Immunology Immunology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (11)

Year:

2025

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Stefanie Hayoz

Head of Statistics

SWITZERLAND

View details

Mattias Mattsson

SWEDEN

View details

Daphne de Jong

University of Amsterdam

NETHERLANDS

View details

Harald Holte

Senior consultant, head of lymphoma section

University of Oslo

NORWAY

View details

Micaela Hernberg

Associate professor

University of Helsinki

FINLAND

View details

Lena Specht

Professor of Oncology

University of Copenhagen

DENMARK

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Eva Kimby

Research Interests

Explore related searches

Contact this professor

Articles (11)

Six-month Rituximab-Lenalidomide regimen in advanced untreated Follicular Lymphoma: SAKK 35/10 Trial 10-year Update.

Personalised therapy in follicular lymphoma – is the dial turning?

Clinical characteristic and outcome of lymphoplasmacytic lymphoma of non‐Waldenstrom macroglobulinemia type: A Swedish lymphoma registry study

The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas

Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy‐free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK)

Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial

The simplified follicular lymphoma PRIMA‐prognostic index is useful in patients with first‐line chemo‐free rituximab‐based therapy

Immunomodulatory drugs may overcome the negative prognostic role of active Th17 axis in follicular lymphoma: evidence from the SAKK35/10 trial

Absolute B cell counts in blood predict long-term response in follicular lymphoma patients treated with rituximab without chemotherapy

Double Hit Lymphoma Diagnosis and Treatment in Europe-A Cross-Sectional Survey of Clinical Practice by the EHA Lymphoma Working Party (EHA LyG)

Increasing prevalence of chronic lymphocytic leukemia with an estimated future rise: A nationwide population-based study

Collaborators (6)

Stefanie Hayoz

Mattias Mattsson

Daphne de Jong

Harald Holte

Micaela Hernberg

Lena Specht

Make your next move.